Long‐term observational studies with cannabis‐based medicines for chronic non‐cancer pain: A systematic review and meta‐analysis of effectiveness and safety
P Bialas, MA Fitzcharles, P Klose… - European Journal of …, 2022 - Wiley Online Library
Abstract Background and Objective This systematic review evaluated the effectiveness,
tolerability and safety of cannabis‐based medicines (CbMs) for chronic non‐cancer pain …
tolerability and safety of cannabis‐based medicines (CbMs) for chronic non‐cancer pain …
The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry
N Dalavaye, S Erridge, M Nicholas, M Pillai… - Expert Review of …, 2023 - Taylor & Francis
Objectives Cannabis-based medicinal products (CBMPs) have shown promising preclinical
activity in inflammatory bowel disease (IBD). However, clinical trials have not demonstrated …
activity in inflammatory bowel disease (IBD). However, clinical trials have not demonstrated …
Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline
JW Busse, P Vankrunkelsven, L Zeng, AF Heen… - bmj, 2021 - bmj.com
Clinical question What is the role of medical cannabis or cannabinoids for people living with
chronic pain due to cancer or non-cancer causes? Current practice Chronic pain is common …
chronic pain due to cancer or non-cancer causes? Current practice Chronic pain is common …
[HTML][HTML] Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies
Objective To establish the prevalence of long-term and serious harms of medical cannabis
for chronic pain. Design Systematic review and meta-analysis. Data sources MEDLINE …
for chronic pain. Design Systematic review and meta-analysis. Data sources MEDLINE …
PEER simplified chronic pain guideline: Management of chronic low back, osteoarthritic, and neuropathic pain in primary care
CS Korownyk, L Montgomery, J Young, S Moore… - Canadian Family …, 2022 - cfp.ca
Objective To develop a clinical practice guideline to support the management of chronic
pain, including low back, osteoarthritic, and neuropathic pain in primary care. Methods The …
pain, including low back, osteoarthritic, and neuropathic pain in primary care. Methods The …
[HTML][HTML] Disorders of cancer metabolism: The therapeutic potential of cannabinoids
D Sun, X Li, S Nie, J Liu, S Wang - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Abnormal energy metabolism, as one of the important hallmarks of cancer, was induced by
multiple carcinogenic factors and tumor-specific microenvironments. It comprises aerobic …
multiple carcinogenic factors and tumor-specific microenvironments. It comprises aerobic …
A placebo-controlled trial of cannabinoid treatment for disruptive behavior in children and adolescents with autism spectrum disorder: effects on sleep parameters as …
A Schnapp, M Harel, D Cayam-Rand, H Cassuto… - Biomedicines, 2022 - mdpi.com
Autism spectrum disorder (ASD) is often associated with debilitating sleep disturbances.
While anecdotal evidence suggests the positive effect of cannabinoids, randomized studies …
While anecdotal evidence suggests the positive effect of cannabinoids, randomized studies …
Evaluation of concomitant use of anticancer drugs and herbal products: from interactions to Synergic Activity
M Berretta, L Dal Lago, M Tinazzi, A Ronchi… - Cancers, 2022 - mdpi.com
Simple Summary Complementary and alternative medicine (CAM) therapies include a wide
range of procedures and products that are often used by cancer patients to directly combat …
range of procedures and products that are often used by cancer patients to directly combat …
Medicinal cannabis for chronic pain: The Bermuda triangle of low‐quality studies, countless meta‐analyses and conflicting recommendations
The combination of the ongoing opioid crisis, inappropriateness of long-term use of NSAIDs,
limited efficacy and tolerability of existing analgesics and the fact that no new analgesics …
limited efficacy and tolerability of existing analgesics and the fact that no new analgesics …
[HTML][HTML] Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of …
L He, J Wang, F Ping, N Yang, J Huang, W Li, L Xu… - bmj, 2022 - bmj.com
Objective To examine the association between dipeptidyl peptidase-4 inhibitors and
gallbladder or biliary diseases. Design Systematic review and pairwise and network meta …
gallbladder or biliary diseases. Design Systematic review and pairwise and network meta …